• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-Fluorouracil drug response.结直肠癌患者胸苷酸合成酶基因结构分析及其与5-氟尿嘧啶药物反应的可能关系。
J Nucleic Acids. 2010 Jan 26;2010:306754. doi: 10.4061/2010/306754.
2
Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.晚期结直肠癌中胸苷酸合成酶(TS)和p16INK4a的免疫组织化学评估:TS表达在基于5-氟尿嘧啶的辅助化疗中的意义
Jpn J Clin Oncol. 2004 Oct;34(10):594-601. doi: 10.1093/jjco/hyh113.
3
Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.胸苷酸合成酶、二氢嘧啶脱氢酶和胸苷磷酸化酶表达在接受辅助性5-氟尿嘧啶治疗的结直肠癌患者中的预测作用
Oncology. 2006;70(5):366-77. doi: 10.1159/000098110. Epub 2006 Dec 15.
4
Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.胸苷酸合成酶在结直肠癌中的表达:基于氟尿嘧啶辅助化疗获益的预后及预测标志物
J Clin Oncol. 2002 Apr 1;20(7):1721-8. doi: 10.1200/JCO.2002.07.039.
5
Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.胸苷酸合成酶基因启动子多态性与结直肠癌中TSmRNA表达相关,但与微卫星不稳定性无关。
Anticancer Res. 2004 Nov-Dec;24(6):3875-80.
6
Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.人胸苷酸合成酶5-氟脱氧尿苷抗性Arg50环突变体的构建与表征
Cancer Res. 2001 Jan 15;61(2):666-72.
7
Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.在13个未经筛选的结肠癌细胞系中,胸苷酸合成酶水平作为对5-氟尿嘧啶敏感性的主要预测参数,但对基于叶酸的胸苷酸合成酶抑制剂则不然。
Clin Cancer Res. 1999 Mar;5(3):643-54.
8
The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells.胸苷酸合成酶和亚甲基四氢叶酸还原酶基因型对结直肠癌细胞5-氟尿嘧啶治疗敏感性的影响
Acta Med Iran. 2017 Dec;55(12):751-758.
9
Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy.原发性结直肠癌中胸苷酸合成酶水平与后续化疗反应之间缺乏相关性。
Br J Cancer. 1997;75(6):903-9. doi: 10.1038/bjc.1997.159.
10
Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.胸苷酸合成酶与结直肠癌中的微卫星不稳定性:对无病生存期、治疗反应及伴转移生存的影响
Acta Oncol. 2008;47(6):1046-53. doi: 10.1080/02841860701678753.

引用本文的文献

1
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex.人源从头胸苷酸合成复合物的胞质定位及体外组装
FEBS J. 2022 Mar;289(6):1625-1649. doi: 10.1111/febs.16248. Epub 2021 Nov 12.
2
MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation.MicroRNA-941 通过改变组蛋白 H3 Ser10 的磷酸化来调节乳腺癌细胞的增殖。
Sci Rep. 2020 Oct 21;10(1):17954. doi: 10.1038/s41598-020-74847-7.
3
Predictive biomarkers for combined chemotherapy with 5-fluorouracil and cisplatin in oro- and hypopharyngeal cancers.口腔和下咽癌中5-氟尿嘧啶和顺铂联合化疗的预测生物标志物。
Mol Clin Oncol. 2018 Feb;8(2):378-386. doi: 10.3892/mco.2017.1521. Epub 2017 Nov 29.
4
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.叶酸表型(FAP)是预测恶性胸膜间皮瘤中基于培美曲塞化疗反应的一种更优生物标志物。
Oncotarget. 2017 Jun 6;8(23):37502-37510. doi: 10.18632/oncotarget.16398.
5
Activation of Two Sequential H-transfers in the Thymidylate Synthase Catalyzed Reaction.胸苷酸合酶催化反应中两个连续氢转移的激活
ACS Catal. 2015 Oct 2;5(10):6061-6068. doi: 10.1021/acscatal.5b01332. Epub 2015 Sep 2.
6
Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer.散发性和遗传性乳腺癌中胸苷酸合成酶基因(TYMS)多态性
BMC Res Notes. 2012 Dec 6;5:676. doi: 10.1186/1756-0500-5-676.

本文引用的文献

1
The role of thymidylate synthase as a molecular biomarker.胸苷酸合成酶作为一种分子生物标志物的作用。
Clin Cancer Res. 2004 Jan 15;10(2):411-2. doi: 10.1158/1078-0432.ccr-1198-03.
2
Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.胸苷酸合成酶在结直肠癌中的表达与预后:一项系统评价和Meta分析
J Clin Oncol. 2004 Feb 1;22(3):529-36. doi: 10.1200/JCO.2004.05.064.
3
Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?通过测量胸苷酸合成酶来确定是否适合用5-氟嘧啶进行治疗,这一方法是否已准备好广泛应用?
Clin Cancer Res. 2003 Apr;9(4):1235-9.
4
Thymidylate synthase: a critical target for cancer chemotherapy.胸苷酸合酶:癌症化疗的关键靶点。
Clin Colorectal Cancer. 2002 Feb;1(4):220-9. doi: 10.3816/CCC.2002.n.003.
5
Failure of detection of the tyrosine to histidine substitution at the residue 33 of thymidylate synthase in human colorectal cancer. A preliminary study.
Anticancer Res. 2000 Nov-Dec;20(6B):4347-50.
6
Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR.通过竞争性聚合酶链反应检测和定量人结肠腺癌细胞系中对5-氟尿嘧啶耐药的胸苷酸合成酶信使核糖核酸
Anticancer Res. 1998 May-Jun;18(3A):1457-63.
7
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.肿瘤内胸苷酸合成酶表达的定量分析可预测播散性结直肠癌对持续输注氟尿嘧啶和每周亚叶酸的反应及耐药性。
J Clin Oncol. 1997 Oct;15(10):3223-9. doi: 10.1200/JCO.1997.15.10.3223.
8
Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy.原发性结直肠癌中胸苷酸合成酶水平与后续化疗反应之间缺乏相关性。
Br J Cancer. 1997;75(6):903-9. doi: 10.1038/bjc.1997.159.
9
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.胸苷酸合成酶基因和蛋白表达相互关联,且与人类结直肠癌和胃癌对5-氟尿嘧啶的反应相关。
Cancer Res. 1995 Apr 1;55(7):1407-12.
10
Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study.
Anticancer Res. 1995 May-Jun;15(3):901-6.

结直肠癌患者胸苷酸合成酶基因结构分析及其与5-氟尿嘧啶药物反应的可能关系。

Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-Fluorouracil drug response.

作者信息

Calascibetta A, Contino Flavia, Feo S, Gulotta G, Cajozzo M, Antona A, Sanguedolce G, Sanguedolce R

机构信息

Dipartimento di Scienze Farmacologiche "Pietro Benigno," Università degli Studi di Palermo, 90100 Palermo, Italy.

出版信息

J Nucleic Acids. 2010 Jan 26;2010:306754. doi: 10.4061/2010/306754.

DOI:10.4061/2010/306754
PMID:20725619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2915790/
Abstract

Thymidylate synthase (TS) catalyzes methylation of dUMP to dTMP and it is the target for the 5-Fluorouracil (5-FU) activity. Barbour et al. showed that variant structural forms of TS in tumour cell lines confer resistance to fluoropyrimidines. We planned to perform the whole TS gene structure by means of sequencing techniques in human colorectal cancer (CRC) samples to try to identify the presence of any possible TS variant form that could be responsible of fluoropyrimidines drug resistance and of the worse prognosis. We performed the TS-DNA gene sequence in 68 CRC from patients of A, B, and C Dukes' stages and different histological grade, but we did not find any mutation in the TS-DNA structure. In the future we intend to widen the TS structure analysis to the metastatic CRCs, because due to their higher genomic instability, they could present a TS variant form responsible of the fluoropyrimidines drug resistance and the worse prognosis.

摘要

胸苷酸合成酶(TS)催化脱氧尿苷一磷酸(dUMP)甲基化生成脱氧胸苷一磷酸(dTMP),它是5-氟尿嘧啶(5-FU)发挥作用的靶点。巴伯等人表明,肿瘤细胞系中TS的变异结构形式赋予了对氟嘧啶的抗性。我们计划通过测序技术对人类结直肠癌(CRC)样本进行完整的TS基因结构分析,以试图确定是否存在任何可能导致氟嘧啶耐药性及预后较差的TS变异形式。我们对处于A、B和C期杜克分期以及不同组织学分级的68例CRC患者进行了TS-DNA基因测序,但未在TS-DNA结构中发现任何突变。未来我们打算将TS结构分析扩展至转移性CRC,因为由于其较高的基因组不稳定性,它们可能存在一种导致氟嘧啶耐药性及预后较差的TS变异形式。